These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25767688)

  • 1. Functional Significance of Cytochrome P450 1A2 Allelic Variants, P450 1A2*8, *15, and *16 (R456H, P42R, and R377Q).
    Lim YR; Kim IH; Han S; Park HG; Ko MJ; Chun YJ; Yun CH; Kim D
    Biomol Ther (Seoul); 2015 Mar; 23(2):189-94. PubMed ID: 25767688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver.
    Yang TJ; Sai Y; Krausz KW; Gonzalez FJ; Gelboin HV
    Pharmacogenetics; 1998 Oct; 8(5):375-82. PubMed ID: 9825829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate-determining steps in phenacetin oxidations by human cytochrome P450 1A2 and selected mutants.
    Yun CH; Miller GP; Guengerich FP
    Biochemistry; 2000 Sep; 39(37):11319-29. PubMed ID: 10985777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, *7, *8, *18, *19, and *35).
    Han S; Choi S; Chun YJ; Yun CH; Lee CH; Shin HJ; Na HS; Chung MW; Kim D
    Biol Pharm Bull; 2012; 35(3):394-9. PubMed ID: 22382327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidations of p-alkoxyacylanilides catalyzed by human cytochrome P450 1A2: structure-activity relationships and simulation of rate constants of individual steps in catalysis.
    Yun CH; Miller GP; Guengerich FP
    Biochemistry; 2001 Apr; 40(14):4521-30. PubMed ID: 11284709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes.
    Yamazaki H; Inoue K; Mimura M; Oda Y; Guengerich FP; Shimada T
    Biochem Pharmacol; 1996 Feb; 51(3):313-9. PubMed ID: 8573198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional influence of human CYP2D6 allelic variations: P34S, E418K, S486T, and R296C.
    Kim J; Lim YR; Han S; Han JS; Chun YJ; Yun CH; Lee CH; Kim D
    Arch Pharm Res; 2013 Dec; 36(12):1500-6. PubMed ID: 23897164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of 7-methoxyresorufin O-demethylation activity of human cytochrome P450 1A2 by molecular breeding.
    Kim D; Guengerich FP
    Arch Biochem Biophys; 2004 Dec; 432(1):102-8. PubMed ID: 15519301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of four allelic variants of human cytochrome P450 1A2.
    Zhou H; Josephy PD; Kim D; Guengerich FP
    Arch Biochem Biophys; 2004 Feb; 422(1):23-30. PubMed ID: 14725854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Characterization of Allelic Variations of Human Cytochrome P450 2C8 (V181I, I244V, I331T, and L361F).
    Lee YB; Kim V; Lee SG; Lee GH; Kim C; Jeong E; Kim D
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme.
    Sandhu P; Guo Z; Baba T; Martin MV; Tukey RH; Guengerich FP
    Arch Biochem Biophys; 1994 Feb; 309(1):168-77. PubMed ID: 8117105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of three CYP1A2 variants found in a Japanese population.
    Saito Y; Hanioka N; Maekawa K; Isobe T; Tsuneto Y; Nakamura R; Soyama A; Ozawa S; Tanaka-Kagawa T; Jinno H; Narimatsu S; Sawada J
    Drug Metab Dispos; 2005 Dec; 33(12):1905-10. PubMed ID: 16174806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate.
    Smith TJ; Guo Z; Guengerich FP; Yang CS
    Carcinogenesis; 1996 Apr; 17(4):809-13. PubMed ID: 8625495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Characterization of 21 Rare Allelic
    Kumondai M; Gutiérrez Rico EM; Hishinuma E; Nakanishi Y; Yamazaki S; Ueda A; Saito S; Tadaka S; Kinoshita K; Saigusa D; Nakayoshi T; Oda A; Hirasawa N; Hiratsuka M
    J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Cloning, Tissue Distribution, and Functional Characterization of Marmoset Cytochrome P450 1A1, 1A2, and 1B1.
    Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2016 Jan; 44(1):8-15. PubMed ID: 26502772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-individual differences in the metabolism of environmental toxicants: cytochrome P450 1A2 as a prototype.
    Guengerich FP; Parikh A; Turesky RJ; Josephy PD
    Mutat Res; 1999 Jul; 428(1-2):115-24. PubMed ID: 10517985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation.
    Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP
    FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro functional analysis of human cytochrome P450 2A13 genetic variants: P450 2A13*2, *3, *4, and *10.
    Kim V; Yeom S; Lee Y; Park HG; Cho MA; Kim H; Kim D
    J Toxicol Environ Health A; 2018; 81(12):493-501. PubMed ID: 29652224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
    Dong MS; Yamazaki H; Guo Z; Guengerich FP
    Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes.
    Murayama N; Soyama A; Saito Y; Nakajima Y; Komamura K; Ueno K; Kamakura S; Kitakaze M; Kimura H; Goto Y; Saitoh O; Katoh M; Ohnuma T; Kawai M; Sugai K; Ohtsuki T; Suzuki C; Minami N; Ozawa S; Sawada J
    J Pharmacol Exp Ther; 2004 Jan; 308(1):300-6. PubMed ID: 14563787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.